Skip to main content
Premium Trial:

Request an Annual Quote

Tom Prescott, Kathleen Lohr, Kieran Gallahue, Laurence Keller, Michael Milanoski, Don Leshnock, Jonathan Davis, Jay Doherty, Kevin McCall, Sarah Abrams, Kathryn West, Michael Wilcox, Christopher Jagoe, Peter Fratangelo, Laurie Sternberg, Ganesh Ramakrishn


Development Executive Joins Forest City to Run Skokie, Ill., Tech Park.
Tom Prescott has joined Forest City Science + Technology Group as senior vice president of its national science and technology group, and project director of the Illinois Science + Technology Park, a redevelopment of the former GD Searle/Pfizer facility into a multi-tenant research campus.
Located in Skokie, Ill., the Illinois Science + Technology Park, is a 23-acre corporate office and research campus offering 660,000 square feet of existing space with advanced facilities. They include chemistry and genomics laboratories, GMP manufacturing suites, clean rooms, NMR suites, research and toxicology labs, conference facilities, and administrative offices, as well as additional build-to-suit opportunities.
Prescott previously served as senior vice president and head of the Chicago office at Irgens Development Partners, which also has offices in Milwaukee and Phoenix.
Forest City Science + Technology Group is a division of Forest City Enterprises, a $10 billion publicly traded real estate company headquartered in Cleveland.

RTI Distinguished Fellow Named to Posts with Advisory Boards ISPOR, NGNQMC
Kathleen Lohr, distinguished fellow withRTI International, a health and pharmaceuticals policy research group in Research Triangle Park, NC, has been appointed to the health science policy council of the International Society of Pharmacoeconomics and Outcomes Research, as well as to the core editorial board of the National Guidelines National Quality Measures Clearinghouses.
At ISPOR, Lohr will serve on the 14-member council that advises the society and its board of directors on key scientific and policy issues related to pharmacoeconomics and outcomes research.
At NGC/NQMC, which is supported by the Agency for Healthcare Research and Quality, Lohr will work with other editorial board members to provide project-specific advice for the development and enhancement of the content of the two clearinghouses.
Lohr is the founding director of the RTI International–University of North Carolina Evidence-based Practice Center, which has completed evidence reports and comparative effectiveness reviews on a broad range of health care topics. She also directs the RTI DEcIDE Center, which carries out projects on comparative effectiveness and safety issues and expands methods for rigorous studies on therapeutics.
Before joining RTI in 1996, Lohr spent nine years at the Institute of Medicine, National Academy of Sciences and 12 years at the RAND Corporation, leading work on quality of care, health insurance and other health care topics.
Lohr holds a doctorate and a master's degree in policy analysis from RAND Graduate Institute, as well as a master's in education and a bachelor's in sociology with distinction from Stanford University.

ResMed Names Global Leader President/CEO as Founder Becomes Executive Chairman
Kieran Gallahue has been appointed president and CEO of ResMed, a San Diego medical equipment manufacturer, by its board of directors, effective Jan. 1. He succeeds company founder Peter Farrell, who continues with ResMed as executive chairman of the board, in accordance with a succession plan announced on Aug. 30.
Gallahue had been president of the company’s international unit, ResMed Global, since September 2004, and currently is a member of the board of directors for Volcano Corporation, a NASDAQ-listed company focusing on diagnosis and treatment of vascular and structural heart disease. Gallahue holds a BA from Rutgers University and an MBA from Harvard Business School.

Aldagen Names Kos Pharmaceuticals Medical Director as New CMO
Laurence Kellerhas been appointed chief medical officer of Aldagen, a Durham, NC, biotechnology company focused on regenerative therapies.
Keller, a board-certified pediatric cardiologist, was previously senior medical director at Kos Pharmaceuticals, recently acquired by Abbott Laboratories. Keller was also formerly senior director for clinical research and development at Pfizer/Parke Davis.
Keller earned a BSci degree from the George Washington University and an MSci degree in physiology from Georgetown University. He earned his MD degree at GWU, then completed his internship and residency at the New York Hospital-Cornell Medical Center. He carried out fellowship training at St. Christopher’s Hospital for Children and Children’s Hospital of Michigan.

Attleboro Redevelopment Authority Director Named Mass. EDC President
Michael Milanoski, the executive director of the Attleboro Redevelopment Authority, has been inaugurated as president of the Massachusetts Economic Development Council .
The council is a professional association for economic development practitioners serving Massachusetts. UnderMilanowski, the ARA developed Attleboro’s new Industrial Business Park, and is working on a $60 million Downtown Development Plan intended to develop more than 500 new housing units within downtown, in a mix of new construction and rehabilitation of older mill buildings. 

Colliers Pinkard Names Broadcasting Executive Director of Business Development
Don Leshnock has joined the commercial real estate firm Colliers Pinkard in Raleigh, NC, as director of business development in the firm’s corporate solutions group.
Leshnock previously worked at Curtis Media Group, North Carolina’s largest radio broadcasting group, and earlier served as national sales manager for CBS Radio in Chicago, where he worked with clients that included Radio Shack, General Motors, and Allied Domecq.

Davis Marcus CEO Heads 2008 Executive Committeee of NAIOP Massachusetts
Jonathan Davis, CEO of Boston office owner-manager Davis Marcus Partners, was elected President of the National Association of Industrial and Office Properties’ Massachusetts chapter for 2008, heading the real estate professional group’s executive committee for this year.
Davis developed properties through his own company from 1976 to 1992, when he joined with Paul Marcus to form the current company. A magna cum laude graduate of Brandeis University, Davis is a member of several non-profit boards, including the Boys and Girls Club of Greater Boston and Combined Jewish Philanthropies of Greater Boston.
Also named to NAIOP Massachusetts’ 2008 executive committee were 19 professionals, of which five are officers:
Other officers of the executive committee officers named executive committee:
  • Jay Doherty, president of the Boston real estate development firm Cabot, Cabot and Forbes, will serve as chairman of the board of directors. Last year Doherty served as chapter president.
  • Kevin McCall, president of Boston-based Paradigm Properties, will serve as president-elect after serving as 2007 senior vice president.
  • Sarah Abrams, president of Fidelity Real Estate Company, was elected treasurer.
  • Kathryn West, vice president of real estate for Partners HealthCare System, will be senior vice president of chapter affairs.
  • Michael Wilcox, director of leasing for the Bulfinch Companies, was elected vice president of chapter affairs.

Law Firm Names New Partner, 2 of Counsel Pros with Life Sciences Experience
Christopher Jagoe, a lawyer specializing in patent litigation and counseling related to biotechnology, pharmaceutical and chemical matters, has been elected one of six new partners at the law firm Kaye Scholer. Jagoe’s experience includes organic synthesis of natural products, fluoropolymers, transgenic crops and insecticides, and ultrasound contrast agents.
Kaye Scholer has also appointed 14 lawyers to the position of counsel, two of which have backgrounds that include the life sciences:
  • Peter Fratangelo focuses his practice on complex patent litigation involving pharmaceuticals, biologics, and genetically modified agricultural products.
  • Laurie Sternberg has significant products liability experience, representing multiple healthcare clients in all aspects of multi-district litigation. She has been an integral part of the national counsel team representing manufacturers of pharmaceutical and implantable devices.

GM of Eli Lilly’s Singapore Operations Joins India Practice of Executive Search Firm

Ganesh Ramakrishnan has joined the life sciences practice of Heidrick & Struggles International, an executive search and leadership consulting firm, as a principal based from the firm’s New Delhi, India, office.

Ramakrishnan previously worked at Eli Lilly, most recently serving as general manager of Lilly's operations in Singapore, where he was also a member of the board of directors of the Singapore Association of Pharmaceutical Industries. Earlier at Eli Lilly he held global marketing and strategy roles with a focus on diabetes, product launch and portfolio strategy.

Before joining Eli Lilly, Ramakrishnan was the founder and CEO of Gobi, an internet start up acquired in 2002. At Gobi, Ganesh served on the company's board of directors with several Fortune 500 CEOs.

He also worked for several years at DE Shaw and Company, a hedge fund, as director of India planning, where he led a principal growth strategy for the firm and evaluated investment opportunities in technology and biotechnology.

Ramakrishnan graduated magna cum laude with highest honors from Harvard University, where he received the Thomas Temple Hoopes Prize, the university's highest academic distinction for undergraduate work. He earned an MBA from INSEAD.

Price Edwards Co-Managing Partner Wins Distinguished Community Service Awar

Carl Edwards will be awarded the Distinguished Community Service award at the annual “Evening of Excellence” black-tie dinner honoring outstanding community and medical leaders. This year’s dinner, sponsored by University of Oklahoma College of Medicine Alumni Association, will be held at the National Cowboy & Western Heritage Museum in Oklahoma City.

Co-managing partner of Price Edwards & Co., the largest Oklahoma-based commercial real estate service company, Edwards has chaired the Presbyterian Health Foundation’s board of trustees for the past four years. He was a trustee in 1993, two years before PHF opened the first of seven buildings in its 27-acre, 600,000-square-foot PHF Research Park.

As PHF chairman, he has been instrumental in continuing its financial support for the OU Health Sciences Center, particularly the support of medical research and biotech commercialization. In his volunteer service he has been vice-chairman of the Greater Oklahoma City Chamber with responsibility for the bioscience center.

Edwards chairs the MAPS for Kids Trust and is vice chair of the Oklahoma City Water Utilities Trust’s board of trustees. Other civic involvements include the boards of the Oklahoma Health Center Foundation, Leadership Oklahoma City, United Way of Metro Oklahoma City and Westminster Presbyterian Church.

Seattle Biomedical Research Institute Names ex-Amgen Executive New VP of Operations

Randy Hassler has been named vice president of operations and finance for the Seattle Biomedical Research Institute, which is establishing the Seattle Structural Genomics Center.

Hassler previously served as a vice president of facility operations at Amgen, and has been a member of the biomedical research institute’s board of trustees for two years. He is also a past member of the institute’s business strategy committee.

Biotech Company Taps Former CFO of Accredo Health for Board Position

Joel Kimbrough, a certified public accountant, was appointed to the board of directors of Aldagen, a biotechnology company in Durham. Kimbrough will also serve as chairman of Aldagen's audit committee.

From 1996 to 2005, Kimbrough served as CFO of Accredo Health, until its acquisition by Medco Health Solutions for about $2.2 billion. As CFO, he managed the company's $48 million initial public offering and all aspects of Accredo's public financial reporting and governance. Kimbrough was Chief Financial Officer of Accredo's predecessor companies from 1989 and was employed by Ernst and Young from 1980 to 1989.

Kimbrough is chair-elect of the Make-A-Wish Foundation of the Mid-South and is a member of the board of directors of Methodist Alliance Homecare, and Trust One Bank.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.